scorecardresearch
Friday, March 29, 2024
Support Our Journalism
HomeWorldFrance plans to ease lockdown in three steps as Covid infections recede

France plans to ease lockdown in three steps as Covid infections recede

Government spokesman Gabriel Attal said the first easing will take place around 1 December, followed by a second one before end-of-the-year holidays and a third from January 2021.

Follow Us :
Text Size:

The French government plans to ease measures put in place against the deadly coronavirus in three steps as infections recede, while keeping some restrictions in place to contain the epidemic.

A first easing will take place “around” Dec. 1, followed by a second one before end-of-the-year holidays and a third from January, government spokesman Gabriel Attal said in an interview with Le Journal du Dimanche.

Confinement measures and travel limitations will remain in place for some time, while venues that have been shut such as restaurants and bars will still face restrictions, Attal told the newspaper. President Emmanuel Macron, who’s due to speak Tuesday, will detail the government strategy for the weeks to come, he said.

Macron faces a difficult balancing act between relieving strained hospital workers and reviving a weakened economy. He’s facing an outcry from owners of small “non-essential” shops who want to reopen as soon as possible. But the epidemic, which has killed more than 48,000 people in France since March, continues to surge.

Macron’s approval rating rose to a six-month high of 41% in an Ifop opinion poll held Nov. 12-19 for Le Journal du Dimanche.

France, which is working on its vaccination strategy, has already signed three contracts with drugmakers, and is in advanced talks for at least three other deals, the government spokesman told the newspaper, without giving more details.

Meanwhile, the country may take additional measures to isolate contaminated individuals and those who have been in contact with them, Attal said.-Bloomberg


Also read: Pfizer Covid vaccine faces hurdles after USFDA filing


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular